On 6/11/2021 Piper Sandler brokerage Initiated Coverage giving a price target of $18.00
VXRT Vaxart today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier. (prnewswire.com)